Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

Authors: Eric A. F. Simões, Shabir A. Madhi, William J. Muller, Victoria Atanasova, Miroslava Bosheva, Fernando Cabañas, Manuel Baca Cots, Joseph B. Domachowske, María Luz García‐García, Ineta Grantiņa, Kim An Nguyen, Heather J. Zar, Anna Berglind, Celeste Cummings, M. Pamela Griffin, Therese Takas, Yuan Yuan, Ulrika Wählby Hamrén, Amanda Leach, Tonya Villafana - The Lancet 2023 cited by 318